UK markets closed

ArcticZymes Technologies ASA (0DRV.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
25.95-0.15 (-0.57%)
At close: 03:19PM BST

ArcticZymes Technologies ASA

Sykehusveien 23
SIVA Innovation Centre PO Box 6463
Tromsø 9294
Norway
47 77 64 89 00
https://arcticzymes.com

Sector(s)
Industry
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Marie Ann Roskrow BSc. (Hons), MBBS (Hons), Ph.D.Executive Chairman500kN/AN/A
Mr. Borge SorvollChief Financial Officer1.75MN/A1975
Dr. Marit Sjo LorentzenVice President of Operations1.26MN/A1968
Mr. Dirk HahneiserVice President of Business Development & Marketing1.57MN/A1968
Mr. Michael Benjamin AkohChief Executive OfficerN/AN/A1973
Dr. Jeremy GillespieVice President of Corporate DevelopmentN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.

Description

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Corporate governance

ArcticZymes Technologies ASA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.